Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802)
241502
Phase 3 mab terminated
Quick answer
Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802) for Hemophilia A is a Phase 3 program (mab) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Hemophilia A
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated